Michael Nagy
Plastic and Reconstructive Surgery · Manasquan, NJNPI 1619913746
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (49.0%), speaking fees and gifts — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by AbbVie at 52.5% of the total. Reporting peaked in 2019 at $7,470 and has fallen 56.1% since, to $3,277 in 2025. Among plastic and reconstructive surgery clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 211 payments — averaging $129.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$14K
- Merz North America, Inc.$10K
- Motiva USA, LLC$1K
- Revance Therapeutics, Inc.$475
- Integra Lifesciences Corporation$339
- Sientra, Inc.$296
- plus $452 from 4 others
What the payments were for
- Speaking & faculty fees$8,09930%
- Travel & lodging$7033%
- Food & beverage$13,41549%
- Gifts$4,84118%
- Other$3261%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 103 | $14,390 |
| Merz North America, Inc. | 66 | $9,942 |
| Motiva USA, LLC | 11 | $1,491 |
| Revance Therapeutics, Inc. | 12 | $475 |
| Integra Lifesciences Corporation | 2 | $339 |
| Sientra, Inc. | 4 | $296 |
| Mentor Worldwide LLC | 8 | $192 |
| Acera Surgical, Inc. | 1 | $161 |
| Musculoskeletal Transplant Foundation Inc. | 3 | $82 |
| Pacira Pharmaceuticals Incorporated | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$27,384 in reported general payments places this provider in the 90th percentile of 93 plastic and reconstructive surgery providers in New Jersey.
See all plastic and reconstructive surgery providers in New Jersey →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 23 | $431 |
| Cephalexin | 39 | $196 |
| Ondansetron OdtOndansetron | 32 | $125 |
| Oxycodone Hcl | 39 | $106 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 14 | $70 |
| Clindamycin Hcl | 12 | $60 |
| Gabapentin | 24 | $41 |
| Diazepam | 20 | $27 |
| Clonidine Hcl | 12 | $5 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Manasquan
- Zachary BorabManasquan$1K
- Sara ColeCherry Hill$63K
- Edward LeeRahway$50K
- Eric ChangFlorham Park$41K
- Colin FaileyFlorham Park$40K
- Steve FallekEnglewood$34K
- Barry DibernardoMontclair$31K
- John TaylorRed Bank$18K
- Francisco ColonFlorham Park$16K
- Peter AndrawesRed Bank$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.